Cancer: Drugs
Commons · Question 112253 · Tabled 10 Feb 2026 · Department of Health and Social Care · Official record
Answered 20 Feb 2026
Question
Asked by Clive Jones
To ask the Secretary of State for Health and Social Care, what steps he is taking to align NICE appraisal timelines, MHRA regulatory pathways and NHS commissioning decisions to support the delivery of personalised cancer medicines.
Answer
Answered by Zubir Ahmed, 20 Feb 2026
The National Institute for Health and Care Excellence (NICE) aims to issue guidance on new medicines close to the time of licensing to ensure that patients benefit from rapid access to clinically and cost effective new medicines. The National Health Servi...